As LAM pathogenesis is characterized by benign tumors with differentiating characteristics towards a mesenchymal phenotype, we postulated that the oncogenic triangle involving LIN28-let-7-HMGA2 observed in most mesenchymal tumors might account for the tumorigenic pathway employed by HMGA2 in LAM. Here, HMGA2 is linked to lymphangioleiomyomatosis.